SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Board Changes

10 Dec 2019 07:00

RNS Number : 2749W
Forterra plc
10 December 2019
 

10 December 2019

 

Forterra plc

Board Changes

 

Forterra plc ("Forterra" or the "Company") announces that Shatish Dasani is stepping down from his role as Chief Financial Officer and as a Director of the Board on 31 December 2019 to pursue other opportunities. Forterra also announces that Ben Guyatt will be appointed as Chief Financial Officer on 1 January 2020 and will join the Board of Forterra at that point.

 

Shatish Dasani joined Forterra in December 2015 and was a key member of the leadership team which successfully took the Company through the IPO in April 2016 and implemented the strategy to drive value for shareholders. In his time with Forterra, he has overseen a significant deleveraging and strengthening of its balance sheet, whilst investing in the core businesses and following a progressive dividend policy.

 

Ben Guyatt has served as Director of Finance and Company Secretary of Forterra since its listing in April 2016 and, prior to this, he was Finance Director of the business at the time of its divestment by HeidelbergCement in 2015. Ben joined Hanson plc in 2006 and held a variety of senior finance and strategy roles within Hanson and HeidelbergCement. Previously Ben held financial management roles at Heath Lambert. The Board believes that Ben will bring a deep and valuable knowledge of Forterra, and the wider market, to the Board.

 

Justin Atkinson, Chairman, commented:

 

"On behalf of the Board I would like to thank Shatish for his substantial contribution to the Company over the last four years and wish him well in the next stage of his career.

 

"I am delighted that Ben will be joining the Board as Chief Financial Officer. Having worked with Ben since the successful IPO, I am convinced he will bring significant knowledge and experience to the Board."

 

Shatish Dasani commented:

 

"I have enjoyed tremendously my time at Forterra and would like to thank the Board and all members of staff for their support. I leave the Group in a strong financial and strategic position, with great potential to continue delivering value for all stakeholders. After four years with the Group, I believe that this is the right time for me to pursue other career opportunities. I wish the team well as they take the business on the next stage of its development."

 

 

Enquiries

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain

Nick Hasell

 

 

The Company confirms that there are no other disclosures to be made in connection with Ben Guyatt's appointment under LR 9.6.13R of the Listing Rules.

 

Shatish Dasani's leaving arrangements have been determined in accordance with our Directors' Remuneration Policy. The statement required by s.430 (2B) of the Companies Act 2006 will be made available for shareholders on the Company's website as soon as reasonably practicable following the date on which Mr Dasani ceases to be a Director.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAVKLFBKLFEFBX
Date   Source Headline
14th Jun 202410:02 amRNSHolding(s) in Company
11th Jun 20244:45 pmRNSAnnual General Meeting 2024 Results - Replacement
10th Jun 202411:39 amRNSHolding(s) in Company
7th Jun 202410:50 amRNSHolding(s) in Company
6th Jun 20243:38 pmRNSDirector/PDMR Shareholding
6th Jun 20243:34 pmRNSDirector/PDMR Shareholding
31st May 20248:12 amRNSDirector/PDMR Shareholding
21st May 20244:39 pmRNSAnnual General Meeting 2024 Results
21st May 20249:00 amRNSDirector/PDMR Shareholding
21st May 20247:50 amRNSProgressive publishes new research
21st May 20247:00 amRNS2024 AGM Trading Update
14th May 202411:44 amRNSHolding(s) in Company
2nd May 202410:46 amRNSGrant under Performance Share Plan
15th Apr 20241:46 pmRNSAnnual Report & Accounts 2023 & Notice of AGM 2024
12th Apr 202412:09 pmRNSDirector/PDMR Shareholding
9th Apr 20244:22 pmRNSDirector/PDMR Shareholding
9th Apr 20244:19 pmRNSDirector/PDMR Shareholding
3rd Apr 20242:19 pmRNSDirector/PDMR Shareholding
27th Mar 20244:44 pmRNSDirector/PDMR Shareholding
25th Jan 202412:27 pmRNSDirector Declaration
24th Jan 20247:19 amRNSProgressive publish new research
24th Jan 20247:00 amRNS2023 Trading Update
23rd Jan 20247:00 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSDirector Declaration
9th Nov 20237:00 amRNSAppointment of Joint Corporate Broker
20th Oct 20236:05 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSQ3 Trading Update
5th Oct 20235:04 pmRNSGrant of Options under 2023 SAYE Scheme
11th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20235:46 pmRNSHolding(s) in Company
23rd Aug 20233:59 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSSix months ended 30 June 2023
11th Jul 20237:00 amRNSPost close half year trading update
5th Jul 202312:39 pmRNSEmployee Benefit Trust Share Purchase
30th Jun 20231:51 pmRNSHolding(s) in Company
6th Jun 202312:57 pmRNSEmployee Benefit Trust Share Purchase
23rd May 20232:22 pmRNSAnnual General Meeting 2023 Results
18th May 202312:12 pmRNSProgressive publish new research
16th May 20237:00 amRNSPre-AGM trading update
5th May 20234:39 pmRNSDirector/PDMR Shareholding
4th May 20239:00 amRNSEmployee Benefit Trust Share Purchase
25th Apr 20237:00 amRNSNotification of Board Changes
11th Apr 20234:15 pmRNSPCA Shareholdings
4th Apr 20231:12 pmRNSEmployee Benefit Trust Share Purchase
3rd Apr 20232:03 pmRNSGrant under Performance Share Plan
29th Mar 202310:21 amRNSAnnual Report & Accounts 2022 & Notice of AGM 2023
16th Mar 20235:28 pmRNSGrant under Deferred Annual Bonus Plan
10th Mar 20239:18 amRNSProgressive publishes new research
9th Mar 20237:02 amRNSAppointment of Independent Non-Executive Director
9th Mar 20237:00 amRNSFull Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.